.Pharmacolibrary.Drugs.ATC.H.H02CA04

Information

name:Levoketoconazole
ATC code:H02CA04
route:oral
compartments:1
dosage:600mg
volume of distribution:24.8L
clearance:5.7L/hr
other parameters in model implementation

Levoketoconazole is the 2S,4R enantiomer of ketoconazole and is used as a cortisol synthesis inhibitor for the treatment of endogenous Cushing’s syndrome in adults. It is an orally active drug and was granted FDA approval in 2021 for this indication.

Pharmacokinetics

Pharmacokinetic parameters in adult patients with Cushing’s syndrome; typical demographic data not restricted by age or sex.

References

    Revisions


    Generated at 2025-08-11T18:21:04Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos